Published Date : Aug 28, 2017
ALBANY, New York, August 28, 2017: One of the critical raw materials required for animal health as well as a key material used in the pharmaceutical industry is fetal bovine serum and this is driving the growth prospects of the global fetal bovine serum market, states a new report that has been added by MarketResearchReports.biz. The report is titled “Global Fetal Bovine Serum Market Research Report 2017.” According to the report, the use of this product for diagnostic, biotechnology and research areas will be a key reason for its high demand. Fetal bovine serum is a safe and effective growth medium for many experimental procedures and thus, it will be in high demand from the aforementioned areas. One of the trends in the global fetal bovine serum market is the shifting to human serum as opposed to animal derivatives as human serum is cost effective and gets easy regulatory approvals. Human serum is suitable especially for new cell line research. In
The growth of the global fetal bovine serum market is hindered by the exponential rise in the cost of this serum in the recent past. The availability of fetal bovine serum is dependent on environmental conditions and thus adverse environmental conditions are creating product shortage. The high demand for beef and dairy is reducing the total population of the cattle herd and this will is another challenge for the market. In addition to this, product recalls have resulted in the shortage of product availability while increasing its cost. All these factors are responsible for restricting the growth of the global fetal bovine serum market. On a brighter note however, the fact that there is no replacement for this product, makes it the prime ingredient of nutrient medium for cell cultures.
For Sample Copy, click here:
On the basis of geography, North America is estimated to lead in the market as new and technologically advanced products are mostly introduced in this part of the world. In addition to this, growing R&D and high demand from research institutes will drive the growth of the North American market for fetal bovine serum. Asia Pacific will continue to show promising growth in fetal bovine serum market. The low labor cost and capital investment required for the manufacturing of this serum in APAC will boost the growth of this market. The high demand for fetal bovine serum of Australian origin is another factor fueling the growth of this market. The growing number of specialty research institutes and cell maintenance banks in Australia is also boosting the growth of the fetal bovine serum market in Asia Pacific.
The report profiles key players operating in the global fetal bovine serum market. Some of them are: Tissue Culture Biologicals, Sigma-Aldrich Co. LLC., PAN-Biotech, GE Healthcare, Rocky Mountain Biologicals, Thermo Fisher Scientific Inc., Atlanta Biologicals, Inc., HiMedia Laboratories, Bovogen Biologicals Pty Ltd., and TCS Biosciences Ltd.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com